A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors
Conditions : Advanced Solid Tumor (Phase 1) Interventions : Drug: HSK46256 Sponsors : Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting
Read the full article17h agoen
You might also wanna read
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Phase 1 trial of ABBV-706 in 288 patients with advanced solid tumors reveals potential in SCLC: 240 on monotherapy, 124 with RR-SCLC. PMID:4
doi.org·7d ago
GSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population
ARTEMIS-008 met its primary endpoint of overall survival in advanced or relapsed small-cell lung cancer
GSK·6h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.